Align Technology (ALGN) |
535.1 -4.37 (-0.81%)
|
01-27 02:36 |
Open: |
541.27 |
Pre. Close: |
539.47 |
High:
|
545 |
Low:
|
530.06 |
Volume:
|
460,888 |
Market Cap:
|
42,193M |
|
|
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign Comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign Moderate, Lite and Express packages, and Invisalign Go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero Scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers; computer-aided design/computer-aided manufacturing services and ancillary products, such as disposable sleeves for the wand; and iTero applications and tools. The company sells its products in the United States, the Netherlands, China, and internationally. Align Technology, Inc. was founded in 1997 and is headquartered in San Jose, California. |
Stock Price Prediction |
Update at 5:00pm EST |
If tomorrow:
|
Open lower
|
Open higher
|
High:
|
545.692 - 548.343 |
548.343 - 550.957 |
Low:
|
522.268 - 525.586 |
525.586 - 528.857 |
Close:
|
528.93 - 534.212 |
534.212 - 539.418 |
|
Technical analysis |
as of: 2021-01-26 4:40:53 PM |
Overall:
|
|
Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
Target: |
Six months: 645.90 One year: 676.86 |
Support: |
Support1: 510.11 Support2: 424.41 |
Resistance: |
Resistance1: 552.99 Resistance2: 579.50 |
Pivot: |
551.34  |
Moving Average: |
MA(5): 543.37 MA(20): 544.83 
MA(100): 439.90 MA(250): 323.30  |
MACD: |
MACD(12,26): 8.40 Signal(9): 13.03  |
Stochastic oscillator: |
%K(14,3): 34.12 %D(3): 38.97  |
RSI: |
RSI(14): 49.51  |
52-week: |
High: 579.50 Low: 127.88 Change(%): 104.5 |
Average Vol(K): |
3-Month: 54192 10-Days: 46391 |
|
Price, moving averages and Bollinger Bands |
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.ALGN has closed above bottom band by 13.5%. Bollinger Bands are 37.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
Headline News |
Wed, 27 Jan 2021 Align Technology (ALGN) Set to Announce Earnings on Wednesday - MarketBeat
Wed, 27 Jan 2021 Brokerages Anticipate Align Technology, Inc. (NASDAQ:ALGN) Will Post Quarterly Sales of $781.97 Million - MarketBeat
Tue, 26 Jan 2021 Align Technology (ALGN) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Mon, 25 Jan 2021 Are Robust Financials Driving The Recent Rally In Align Technology, Inc.'s (NASDAQ:ALGN) Stock? - Simply Wall St
Sat, 23 Jan 2021 $ALGN Pre-earnings Momentum Trade With a Technical Trigger - CML News
Fri, 22 Jan 2021 Should You Buy Align Technology, Inc. (ALGN) Stock? - InvestorsObserver
|
Financial Analysis |
Growth |
 |
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
Profitability |
 |
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
Solvency |
 |
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
Efficiency |
 |
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
Free Technical Analysis Charts
|
|
Stock Basics & Statistics |
Exchange: NASDAQ |
Sector: Healthcare |
Industry: Medical Devices |
Shares Out. (M) |
79 |
Shares Float (M) |
73 |
% Held by Insiders
|
7.94 |
% Held by Institutions
|
89.51 |
Shares Short (K)
|
1,440 |
Shares Short P. Month (K)
|
1,990 |
Stock Financials |
EPS
|
21.980 |
EPS Est This Year
|
3.410 |
EPS Est Next Year
|
4.090 |
Book Value (p.s.)
|
38.470 |
Profit Margin
|
76.00 |
Operating Margin
|
14.21 |
Return on Assets (ttm)
|
6.0 |
Return on Equity (ttm)
|
80.1 |
Qtrly Rev. Growth
|
20.9 |
Gross Profit (p.s.)
|
22.067 |
Sales Per Share
|
29.042 |
EBITDA (p.s.)
|
5.347 |
Qtrly Earnings Growth
|
35.90 |
Operating Cash Flow (M)
|
499 |
Levered Free Cash Flow (M)
|
359 |
Stock Valuations |
PE Ratio
|
24.34 |
PEG Ratio
|
4.17 |
Price to Book value
|
13.91 |
Price to Sales
|
18.42 |
Price to Cash Flow
|
84.57 |
Stock Dividends |
Dividend
|
|
Forward Dividend
|
|
Dividend Yield
|
|
Dividend Pay Date
|
Invalid DateTime. |
Ex-Dividend Date
|
Invalid DateTime. |
7 Binary Options
|
Your Ad Here
|
|